{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:07:37Z","timestamp":1785204457483,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Astellas Pharma Global Development, Inc., Northbrook, IL, US."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12889-019-6932-9","type":"journal-article","created":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T15:04:22Z","timestamp":1558105462000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Burden of hospitalizations over time with invasive aspergillosis in the United States, 2004\u20132013"],"prefix":"10.1186","volume":"19","author":[{"given":"Marya D.","family":"Zilberberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Spalding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew F.","family":"Shorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"6932_CR1","unstructured":"Health Resources and Services Administration, U.S. Department of Health & Human Services. Organ procurement and transplantation network: view data reports. Available from: \n                    https:\/\/optn.transplant.hrsa.gov\/data\/view-data-reports\/\n                    \n                  . [accessed: 14 May 2017]."},{"key":"6932_CR2","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S1473-3099(05)70238-3","volume":"5","author":"WW Hope","year":"2005","unstructured":"Hope WW, Walsh TJ, Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis. 2005;5:609\u201322.","journal-title":"Lancet Infect Dis"},{"key":"6932_CR3","doi-asserted-by":"publisher","first-page":"ofw268","DOI":"10.1093\/ofid\/ofw268","volume":"4","author":"S Vallabhaneni","year":"2017","unstructured":"Vallabhaneni S, Benedict K, Derado G, Mody RK. Trends in hospitalizations related to invasive aspergillosis and mucormycosis in the United States, 2000\u20132013. Open Forum Infect Dis. 2017;4:ofw268. \n                    https:\/\/doi.org\/10.1093\/ofid\/ofw268\n                    \n                  .","journal-title":"Open Forum Infect Dis"},{"key":"6932_CR4","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1086\/317487","volume":"31","author":"EJ Dasbach","year":"2000","unstructured":"Dasbach EJ, Davies GM, Teutsch SM. Burden of aspergillosis-related hospitalizations in the United States. Clin Infect Dis. 2000;31:1524\u20138.","journal-title":"Clin Infect Dis"},{"key":"6932_CR5","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1097\/CCM.0b013e3181691a49","volume":"36","author":"MD Zilberberg","year":"2008","unstructured":"Zilberberg MD, de Wit M, Pirone JR, Shorr AF. Growth in adult prolonged acute mechanical ventilation: implications for healthcare delivery. Crit Care Med. 2008;36:1451\u20135.","journal-title":"Crit Care Med"},{"key":"6932_CR6","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3201\/eid1406.071447","volume":"14","author":"MD Zilberberg","year":"2008","unstructured":"Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000\u20132005. Emerg Infect Dis. 2008;14:929\u201331.","journal-title":"Emerg Infect Dis"},{"key":"6932_CR7","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1097\/INF.0b013e31817eef13","volume":"27","author":"MD Zilberberg","year":"2008","unstructured":"Zilberberg MD, Shorr AF, Kollef MH. Increase in Clostridium difficile-related hospitalizations among infants in the United States, 2000\u20132005. Pediatr Infect Dis J. 2008;27:1111\u20133.","journal-title":"Pediatr Infect Dis J"},{"key":"6932_CR8","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.3201\/eid1408.080446","volume":"14","author":"MD Zilberberg","year":"2008","unstructured":"Zilberberg MD. Assessment of reporting bias for Clostridium difficile hospitalizations, United States. Emerg Infect Dis. 2008;14:1334.","journal-title":"Emerg Infect Dis"},{"key":"6932_CR9","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/591033","volume":"29","author":"MD Zilberberg","year":"2008","unstructured":"Zilberberg MD, Shorr AF, Kollef MH. Secular trends in candidemia-related hospitalization in the United States, 2000\u20132005. Infect Control Hosp Epidemiol. 2008;29:978\u201380.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"6932_CR10","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1111\/j.1532-5415.2008.02026.x","volume":"56","author":"MD Zilberberg","year":"2008","unstructured":"Zilberberg MD, Shorr AF, Kollef MH. Growth in the incidence of hospitalizations with resistant infections in elderly people in the United States: 2000 to 2006. J Am Geriatr Soc. 2008;56:2356\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"6932_CR11","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.3201\/eid1411.080337","volume":"14","author":"MD Zilberberg","year":"2008","unstructured":"Zilberberg MD, Shorr AF, Kollef MH. Growth and geographic variation in hospitalizations with resistant infections, United States, 2000\u20132005. Emerg Infect Dis. 2008;14:1756\u20138.","journal-title":"Emerg Infect Dis"},{"key":"6932_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3201\/eid1501.080793","volume":"15","author":"MD Zilberberg","year":"2009","unstructured":"Zilberberg MD. Clostridium difficile-related hospitalizations among US adults, 2006. Emerg Infect Dis. 2009;15:122\u20134.","journal-title":"Emerg Infect Dis"},{"key":"6932_CR13","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1086\/593956","volume":"30","author":"A Ramsey","year":"2009","unstructured":"Ramsey A, Zilberberg MD. Secular trends of hospitalization with vancomycin-resistant Enterococcus in the United States, 2000-2006. Infect Control Hosp Epidemiol. 2009;30:184\u20136.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"6932_CR14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/1472-6963-8-242","volume":"8","author":"MD Zilberberg","year":"2008","unstructured":"Zilberberg MD, Shorr AF. Prolonged acute mechanical ventilation and hospital bed utilization in 2020 in the United States: implications for budgets, plant and personnel planning. BMC Health Serv Res. 2008;8:242.","journal-title":"BMC Health Serv Res"},{"key":"6932_CR15","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3201\/eid1604.090680","volume":"16","author":"MD Zilberberg","year":"2010","unstructured":"Zilberberg MD, Tillotson GS, McDonald LC. Clostridium difficile infections among hospitalized children, United States, 1997\u20132006. Emerg Infect Dis. 2010;16:604\u20139.","journal-title":"Emerg Infect Dis"},{"key":"6932_CR16","unstructured":"HCUPnet. Available from: \n                    https:\/\/hcupnet.ahrq.gov\/#setup\n                    \n                  . [accessed: 6 Dec 2017]."},{"key":"6932_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1086\/524324","volume":"29","author":"DC Chang","year":"2008","unstructured":"Chang DC, Burwell LA, Lyon GM, Pappas PG, Chiller TM, Wannemuehler KA, Fridkin SK, Park BJ. Comparison of the use of administrative data and an active system for surveillance of invasive aspergillosis. Infect Control Hosp Epidemiol. 2008;29:25\u201330.","journal-title":"Infect Control Hosp Epidemiol"},{"key":"6932_CR18","unstructured":"US Census Bureau. Available at \n                    http:\/\/www.census.gov\/\n                    \n                  . [accessed: 17 Dec 2016]."},{"key":"6932_CR19","unstructured":"The US Bureau of Labor Statistics. Consumer Price Index. Available from: \n                    http:\/\/www.bls.gov\/data\/#calculators\n                    \n                  . [accessed: 6 Dec 2017]."},{"issue":"5","key":"6932_CR20","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/cid\/ciy181","volume":"67","author":"MD Zilberberg","year":"2018","unstructured":"Zilberberg MD, Nathanson BH, Harrington R, Spalding JR, Shorr AF. Epidemiology and outcomes of hospitalizations with invasive aspergillosis in the United States, 2009\u20132013. Clin Infect Dis. 2018;67(5):727\u201335. \n                    https:\/\/doi.org\/10.1093\/cid\/ciy181\n                    \n                  .","journal-title":"Clin Infect Dis"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6932-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12889-019-6932-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-019-6932-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T23:23:02Z","timestamp":1589584982000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-019-6932-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["6932"],"URL":"https:\/\/doi.org\/10.1186\/s12889-019-6932-9","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,17]]},"assertion":[{"value":"7 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Rachel Harrington was affiliated to Astellas Pharma Global Development, Inc., Northbrook, IL, USA at the time of the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 information"}},{"value":"The data used in this study are all de-identified and publicly available, obviating the requirement for an ethics committee evaluation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"MDZ reports grants from EviMed Research Group, LLC and Astellas Pharma Inc., during the conduct of the study, personal fees from Paratek, Tetraphase, Melinta, Achaogen, Pfizer, Shionogi, and Cleveland Clinic, grants from Merck and The Medicines Company, and stock ownership from Johnson & Johnson, outside the submitted work; RH was an employee of Astellas Pharma Global Development, Inc. at the time of study and is currently supported by NCI training grant 5R25-CA057699; JS is an employee of Astellas Pharma Global Development, Inc.; AFS has received consultancy fees, research support, and speaker honoraria from Astellas and Merck, and consultancy fees from Cidara.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"591"}}